168 related articles for article (PubMed ID: 38240146)
1. Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
Susila S; Ilmakunnas M; Lauronen J; Vuorinen P; Ångerman S; Sainio S
Transfusion; 2024 May; 64 Suppl 2():S119-S125. PubMed ID: 38240146
[TBL] [Abstract][Full Text] [Related]
2. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
[TBL] [Abstract][Full Text] [Related]
3. Maternal and child life years gained by transfusing low titer group O whole blood in trauma: A computer simulation.
Yazer MH; Leeper C; Spinella PC; Emery SP; Horvath S; Seheult JN
Transfusion; 2024 May; 64 Suppl 2():S93-S99. PubMed ID: 38404198
[TBL] [Abstract][Full Text] [Related]
4. Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma.
Yazer MH; Panko G; Holcomb JB; Kaplan A; Leeper C; Seheult JN; Triulzi DJ; Spinella PC
Hematology; 2023 Dec; 28(1):2161215. PubMed ID: 36607150
[TBL] [Abstract][Full Text] [Related]
5. Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review.
Yazer M; Triulzi D; Sperry J; Corcos A; Seheult J
Hematology; 2021 Dec; 26(1):321-327. PubMed ID: 33775237
[TBL] [Abstract][Full Text] [Related]
6. Ethical considerations in the use of RhD-positive blood products in trauma.
Malone JR
Transfusion; 2024 May; 64 Suppl 2():S4-S10. PubMed ID: 38491917
[TBL] [Abstract][Full Text] [Related]
7. Estimating the risks of prehospital transfusion of D-positive whole blood to trauma patients who are bleeding in England.
Cardigan R; Latham T; Weaver A; Yazer M; Green L
Vox Sang; 2022 May; 117(5):701-707. PubMed ID: 35018634
[TBL] [Abstract][Full Text] [Related]
8. Survey of policies at US hospitals on the selection of RhD type of low-titer O whole blood for use in trauma resuscitation.
Clayton S; Leeper CM; Yazer MH; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S111-S118. PubMed ID: 38501231
[TBL] [Abstract][Full Text] [Related]
9. Management Considerations for Air Medical Transport Programs Transfusing RhD-Positive Red Blood Cell-Containing Products to Females of Childbearing Potential.
McCartin MP; Wool GD; Thomas SA; Panfil M; Schoenfeld D; Blumen IJ; Tataris KL; Thomas SH
Air Med J; 2024; 43(4):348-356. PubMed ID: 38897700
[TBL] [Abstract][Full Text] [Related]
10. Safety profile of low-titer group O whole blood in pediatric patients with massive hemorrhage.
Morgan KM; Yazer MH; Triulzi DJ; Strotmeyer S; Gaines BA; Leeper CM
Transfusion; 2021 Jul; 61 Suppl 1():S8-S14. PubMed ID: 34269441
[TBL] [Abstract][Full Text] [Related]
11. Use of Low-Titer O-Positive Whole Blood in Female Trauma Patients: A Literature Review, Qualitative Multidisciplinary Analysis of Risk/Benefit, and Guidelines for Its Use as a Universal Product in Hemorrhagic Shock.
Clements TW; Van Gent JM; Menon N; Roberts A; Sherwood M; Osborn L; Hartwell B; Refuerzo J; Bai Y; Cotton BA
J Am Coll Surg; 2024 Mar; 238(3):347-357. PubMed ID: 37930900
[TBL] [Abstract][Full Text] [Related]
12. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
[TBL] [Abstract][Full Text] [Related]
13. Survey of the RhD selection and issuing practices for uncrossmatched blood products at pediatric trauma hospitals in the United States: The BEST collaborative study.
Yazer MH; Dunbar NM; Delaney M;
Transfusion; 2021 Dec; 61(12):3328-3334. PubMed ID: 34595764
[TBL] [Abstract][Full Text] [Related]
14. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
[TBL] [Abstract][Full Text] [Related]
15. Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
Seheult JN; Callum J; Delaney M; Drake R; Dunbar NM; Harm SK; Hess JR; Jackson BP; Javanbakht A; Moore SA; Murphy MF; Raval JS; Staves J; Tuott EE; Wendel S; Ziman A; Yazer MH;
Transfusion; 2022 Aug; 62 Suppl 1():S185-S192. PubMed ID: 35748692
[TBL] [Abstract][Full Text] [Related]
16. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
[TBL] [Abstract][Full Text] [Related]
17. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
[TBL] [Abstract][Full Text] [Related]
18. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
Yazer MH; Triulzi DJ; Sperry JL; Seheult JN
Transfusion; 2021 Jul; 61 Suppl 1():S150-S158. PubMed ID: 34269438
[TBL] [Abstract][Full Text] [Related]
19. Safety profile of uncrossmatched, cold-stored, low-titer, group O+ whole blood in civilian trauma patients.
Seheult JN; Bahr M; Anto V; Alarcon LH; Corcos A; Sperry JL; Triulzi DJ; Yazer MH
Transfusion; 2018 Oct; 58(10):2280-2288. PubMed ID: 29802644
[TBL] [Abstract][Full Text] [Related]
20. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
